1. MTHFR homozygous mutation and additional risk factors for cerebral infarction in a large Italian family.
- Author
-
Del Balzo F, Spalice A, Perla M, Properzi E, and Iannetti P
- Subjects
- Cerebral Infarction diagnosis, Child, Epilepsy etiology, Epilepsy physiopathology, Family, Female, Frontal Lobe pathology, Humans, Infant, Infant, Newborn, Italy, Magnetic Resonance Imaging, Male, Paresis etiology, Paresis pathology, Paresis physiopathology, Pedigree, Risk Factors, Subthalamus pathology, Temporal Lobe pathology, Cerebral Infarction complications, Cerebral Infarction genetics, Factor VII metabolism, Methylenetetrahydrofolate Reductase (NADPH2) genetics, Mutation, Protein C metabolism
- Abstract
Several cases with cerebral infarctions associated with the C677T mutation in the methylenetetrahydrofolate reductase gene (MTHFR) have been reported. Given the large number of asymptomatic individuals with the MTHFR mutation, additional risk factors for cerebral infarction should be considered. This study describes a large family with the MTHFR mutation and a combination of heterozygous factor V Leiden mutations and different additional exogenous and endogenous thrombogenic risk factors. Psychomotor retardation and a left fronto-insular infarct associated with the MTHFR mutation together with diminished factor VII and low level of protein C was documented in the first patient. In the second patient, generalized epilepsy and a malacic area in the right nucleus lenticularis was associated with the MTHFR mutation and a low level of protein C. In the third patient, right hemiparesis and a left fronto-temporal porencephalic cyst were documented, together with the MTHFR mutation and hyperhomocysteinemia. An extensive search of additional circumstantial and genetic thrombogenic risk factors should be useful for prophylaxis and prognosis of infants with cerebral infarctions associated with the MTHFR mutation and of their related family members.
- Published
- 2009
- Full Text
- View/download PDF